跳至主要内容
临床试验/NCT04604665
NCT04604665已完成不适用

Evaluation of the Efficacy of Two Levels of Frequency of Repositioning in Adults Hospitalized in Intensive Care Units, in the Reduction of Pressure Ulcers: A Randomized Cluster Study.

Fundación Cardioinfantil Instituto de Cardiología21 个研究点 分布在 1 个国家目标入组 3,300 人开始时间: 2021年4月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,300
试验地点
21
主要终点
The incidence (incidence rata ration) of new pressure ulcers in each Intensive Care Unit (ICU)

研究概览

简要总结

PENFUP FASE 2, It is a multicenter study by parallel conglomerates, planned in order to evaluate the efficacy between two levels of frequency of postural change in intensive care units for adults of hospitals in various regions of Colombia.

详细描述

Taking into account a design effect of 6.7, Investigators planned to include 150 participants from each ICU. Investigators did calculate that a total of 22 ICUs are required, in which 11 will be assigned to the low frequency and 11 will be assigned to a high frequency group of postural change until obtaining a total of 1,650 patients in each arm of the study and a total of 3,300 participants in the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

Telephone randomization Random numbers centers Blinded for analyst and researchers

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The ICU manage adult patients, over 18 years of age, with any type of emphasis (surgical, medical, neurological, or mixed);
  • •Patients are admitted in critical condition (with life support);
  • •The director accepts the commitment of the care assigned in the randomization (for a period of 3 months).

排除标准

  • •Intermediate care units in which patients mobilize themselves.
  • •Covid patients or other patients exposed to different mobilization patterns (e.g., 12 hours prone vs 12 supine)

研究组 & 干预措施

High frequency postural change

Experimental

Repositioning or rotation of patients hospitalized in bed in intensive care units will be carried out with a frequency interval that we call "high-frequency". It has to be performed on each patient between an interval less than or equal to every 2 hours in a full day (24 hours) (minimum goal of 8-10 in 24 hours subtracting 2 or 4 at night and not alter the circadian cycle). The position must be modified in each postural change to the right lateral, supine, left lateral, supine, or prone position to supine position. The repositioning will be provided until a patient is discharged from ICU, die or begin ambulation. When providing each repositioning, avoid dragging the patient, the shear, and the friction to increase UPP risk. This must be applied to avoiding massage. Patients in any position should use pressure-reducing items such as pillows.

干预措施: High frequency postural change (Other)

Conventional care

Active Comparator

Repositioning or rotation of patients hospitalized will be the conventional or usual care. Units in this group are not going to receive any intervention. Will be only observed in their current intervention of repositioning.

干预措施: Conventional care (Other)

结局指标

主要结局

The incidence (incidence rata ration) of new pressure ulcers in each Intensive Care Unit (ICU)

时间窗: " 1 month after admission"

The number of pressure injuries at any stage, new acquired in the ICU after admission per 1,000 patient days in the ICU.

次要结局

  • Security outcomes("1 month after admission")
  • Risk index (HR) and time to event of Pressure ulcers of the patients("1 month safter admission")

研究者

发起方
Fundación Cardioinfantil Instituto de Cardiología
申办方类型
Other
责任方
Principal Investigator
主要研究者

Olga Cortés, RN, MSc, PhD

Reseear Associated, Research Department, Principal Investigator

Fundación Cardioinfantil Instituto de Cardiología

研究点 (21)

Loading locations...

相似试验

进行中(未招募)
2 期
DexICE therapy for refractory LBRefractory or recurrent lymphoblastic lymphoma.0054198Non-Hodgkin lymphoma
JPRN-jRCTs041180184Mitsui Tetsuo24
进行中(未招募)
不适用
Phase II multicentric study to evaluate the efficacy and the safety of Bendamustine in adjunct to Etoposide, Aracytabin and Melphalan (BeEAM) as a preparative regimen for autologous stem cell transplantation in refractory/relapsed lymphoma patients. - BeEAMDiagnosis of Non-Hodgkin lymphoma of any subtype, chronic lymphocytic leukemia, or Hodgkin disease either refractory or relapsed after at least one line of chemotherapy.MedDRA version: 9.1Level: HLGTClassification code 10025320MedDRA version: 9.1Level: HLGTClassification code 10025319
EUCTR2008-002736-15-ITAZIENDA OSPEDALIERA OSPEDALE S. SALVATORE
进行中(未招募)
不适用
study to evaluate the efficacy of a preparative regimen for transplantation in refractory/relapsed non-Hodgkin lymphoma patients.Adult agressive B-cell non-Hodgkin lymphoma patients.MedDRA version: 14.1Level: PTClassification code 10012821Term: Diffuse large B-cell lymphoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 14.1Level: HLGTClassification code 10025320Term: Lymphomas non-Hodgkin's B-cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 14.1Level: PTClassification code 10012822Term: Diffuse large B-cell lymphoma refractorySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2011-001246-14-ITAZIENDA OSPEDALIERA OSPEDALE S. SALVATORE
已完成
2 期
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial ConjunctivitisAcute Bacterial Conjunctivitis
NCT05816070IVIEW Therapeutics Inc.129
Unknown
2 期
Study of the Apatinib Combine With POF Versus POF in Gastric CancerGastric AdenocarcinomaAdvanced Cancer
NCT04121039Fujian Cancer Hospital116
Evaluation of Two Levels of Frequency of... | 临床试验